News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Preclinical Studies Underway On Advanced Refractive Technologies Inc. Novel Glaucoma Treatment


9/13/2006 2:27:53 PM

SAN CLEMENTE, Calif., Sept. 13 /PRNewswire-FirstCall/ -- Preclinical testing has begun on the novel glaucoma treatment recently licensed by Advanced Refractive Technologies (OTC Bulletin Board: ARFR - News). This first step in clinical trials will assess the safety and efficacy of the compound before the initiation of human trials. The in vitro portion of this testing will require approximately six months to complete at which time the in vivo testing will begin. After six months of this in vivo testing, the Phase One human trials should be underway.

Read at press release


comments powered by Disqus
   
Glaucoma

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES